HUMA – humacyte, inc. (US:NASDAQ)
Stock Stats
News
Humacyte (HUMA) had its "sell (e+)" rating reaffirmed by Weiss Ratings.
Humacyte (HUMA) was downgraded by Wall Street Zen from "sell" to "str
Did Humacyte, Inc. Insiders Breach their Fiduciary Duties to Shareholders? [TheStreet.com]
Did Humacyte, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Humacyte (HUMA) had its price target lowered by Barclays PLC from $3.50 to $1.50. They now have an "overweight" rating on the stock.
Form 10-K Humacyte, Inc. For: Dec 31
Form SCHEDULE 13D/A Humacyte, Inc. Filed by: FRESENIUS MEDICAL CARE HOLDINGS INC /NY/
Form 8-K Humacyte, Inc. For: Mar 19
Form 424B3 Humacyte, Inc.
Form 8-K Humacyte, Inc. For: Mar 19
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.